Matthew Tegtmeyer
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
Publications
36
Citations
738
Est. group size
~5
Recurring co-author estimate
Active years
8
Publishing since 2019
Matthew Tegtmeyer studies how genetic variation affects brain cells, using stem-cell-derived neurons and astrocytes to model diseases such as Huntington's disease, Alzheimer's disease, schizophrenia, and 22q11.2 deletion syndrome. The work combines gene editing, single-cell genomics, and image-based cell profiling to link specific genes to changes in cell shape, molecular signatures, and disease-relevant behavior. Prospective students would likely engage with computational and wet-lab methods for studying human genetic risk factors in cellular disease models.
Publication output has grown substantially over the last decade, rising from zero or minimal output before 2019 to a peak of around 9-10 papers per year in 2023 and 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Antisense oligonucleotide–mediated MSH3 suppression reduces somatic CAG repeat expansion in Huntington’s disease iPSC–derived striatal neurons
Science Translational Medicine · 2025
- Combining phenomics with transcriptomics reveals cell-type-specific morphological and molecular signatures of the 22q11.2 deletion
Nature Communications · 2025
- Explainable modeling of single-cell perturbation data using attention and sparse dictionary learning
Cell Systems · 2025
- Abnormal Lipid Metabolism and Altered Neuronal Support by Astrocytes Lacking <i>Akap11</i> , a Risk Gene for Schizophrenia and Bipolar Disorder
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Astrocytic-supplied cholesterol drives synaptic gene expression programs in developing neurons and downstream astrocytic transcriptional programs
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Human genetic variation shapes the response of neurons to interferons
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Functional consequences of genetic risk for neuropsychiatric conditions at chr22q
medRxiv · 2025
- Gene editing in “cell villages” enables exploring disease-relevant mutations in many genetic backgrounds
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Brain Chimeroids reveal individual susceptibility to neurotoxic triggers
Nature · 2024
- High-dimensional phenotyping to define the genetic basis of cellular morphology
Nature Communications · 2024
- 735 Econazole selectively induces cell death in NF1-homozygous mutant tumor cells
Journal of Investigative Dermatology · 2024
- Combining NeuroPainting with transcriptomics reveals cell-type-specific morphological and molecular signatures of the 22q11.2 deletion
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Modeling interpretable correspondence between cell state and perturbation response with CellCap
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- W78. GENE REGULATORY NETWORKS OF CHOLESTEROL BIOSYNTHESIS IN ASTROCYTES AND THEIR IMPACT ON NEURONAL SYNAPTIC FUNCTION IN SCHIZOPHRENIA
European Neuropsychopharmacology · 2024
- Early Alzheimer’s disease pathology in human cortex involves transient cell states
Cell · 2023
- bioRxiv (Cold Spring Harbor Laboratory)×16
- Nature Communications×3
- European Neuropsychopharmacology×3
- Cell×1
- Cell stem cell×1
- Dominic J. Acri
Biochemistry, Genetics and Molecular Biology · Indiana University
- Meng Zhang
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Qi Guo
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Ellen M. Quardokus
Biochemistry, Genetics and Molecular Biology · Indiana University
- Bruce W. Herr
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile